Search
for
Sort by
Research 61–90 of 445
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Successful Management of Netherton Syndrome Using IVIG and Dupilumab: A Case Report
- The use of dupilumab for the treatment of alopecia areata
- Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
- BH02 (P100) Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice
- P100 Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Efficacy of Dupilumab in Patients with Atopic Dermatitis and Alopecia Areata: A Case Series
- Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report
- Complete hair regrowth in a young male with severe atopic dermatitis and alopecia areata after dupilumab: probably more than a coincidence
- Dupilumab: Friend or Foe to Alopecia Areata?
- Dupilumab and ritlecitinib combination therapy in a patient with alopecia totalis and atopic disease
- 20 Exosomes derived from adipose tissue-derived mesenchymal stem cells (ASCE) for the treatment of dupilumab-related facial redness in patients with atopic dermatitis
- 272 Dupilumab treatment in children with alopecia areata: A real-world, single-center observational study
- Early onset of alopecia areata after dupilumab introduction in a patient with atopic dermatitis
- 42008 Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
- 089 Single-cell RNA sequencing defines molecular similarities between patch/plaque-stage mycosis fungoides and atopic dermatitis under dupilumab
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- New developments in the molecular treatment of ichthyosis: review of the literature
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28‐Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
- Biologics in the management of childhood atopic dermatitis
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Drug-induced alopecia areata: A systematic review